Researchers at Columbia Engineering report that their newly developed robotic Trunk Support Trainer (TruST), when combined with active practice of postural movements, improves trunk and reaching control in children with ceerebral palsy (CP) who have impaired sitting control.
A beta test of a program for older adults who undergo major surgery has resulted in shorter hospital stays and lower rates of post-surgery delirium, among other improved outcomes, according to research presented recently at the virtual American College of Surgeons (ACS) Clinical Congress 2020.
Biodex Medical Systems Inc, Shirley, NY, announces that the medBike is now part of its family of Balance and Mobility physical medicine devices.
She has no hands or feet. Her physician says a power wheelchair is necessary and Blue Cross Blue Shield says, “Not so much.”
The Hanging Handles by Bob and Brad are an exclusive new training product created by physical therapists Bob Schrupp and Brad Heineck. Available from OPTP, Minneapolis, they provide a simple, easy way to perform exercises to help decompress the thoracic and lumbar spine (mid- and low-back) and promote the health and range of motion of the shoulders.
A diet high in dried plum (prunes) completely prevents bone loss associated with spinal cord injury (SCI), while also restoring some of the bone lost following SCI, researchers suggest, the Journal of the Orthopaedic Research Society - Spine.
Tekscan Inc, a manufacturer of flexible, ultra-thin sensors and systems, was acquired by Artemis Capital Partners, a Boston-based private equity firm focused exclusively on partnering with differentiated industrial technology companies, according to a media release.
Reportedly the first-ever Consensus Document offers recommended approaches for treating knee osteoarthritis (OA) patients based on their age and activity level. A global panel of more than 40 experts in various orthopaedic disciplines compiled the document.
AbbVie announces that the US Food and Drug Administration (FDA) has granted Orphan Drug and Fast Track designations for elezanumab (ABT-555), an investigational treatment for patients following spinal cord injury.